Mitochondria-targeted NO donor enables synergistic NO and photodynamic therapies for effective inhibition of cancer cell proliferation and migration
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Nitric Oxide and Endothelin Effects · Photodynamic Therapy Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. Cancer statistics, 2023, CA cancer
3. Surgery for cancer: a trigger for metastases10.1158/0008-5472.CAN-16-1536 ↗
4. Estimating the global demand and delivery of cancer surgery10.1007/s00268-019-05035-6 ↗
5. The advances in epigenetics for cancer radiotherapy
6. Radiotherapy of cervical cancer10.1016/j.canrad.2021.11.009 ↗
7. Targeted gold nanocluster-enhanced radiotherapy of prostate cancer10.1002/smll.201900968 ↗
8. Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics
9. Chemotherapy: a double-edged sword in cancer treatment, Cancer Immunol
10. Tumour stem cells and drug resistance10.1038/nrc1590 ↗
11. Tumor metastasis: molecular insights and evolving paradigms10.1016/j.cell.2011.09.024 ↗
12. Multifunctional tumor pH-sensitive self-assembled nanoparticles for bimodal imaging and treatment of resistant heterogeneous tumors10.1021/ja4108287 ↗
13. Targeting hypoxia in cancer therapy10.1038/nrc3064 ↗
14. Nanotechnology for multimodal synergistic cancer therapy10.1021/acs.chemrev.7b00258 ↗
15. Photodynamic therapy for cancer10.1038/nrc1071 ↗
16. Activatable photosensitizers: agents for selective photodynamic therapy10.1002/adfm.201604053 ↗
17. Transition metal complexes as photosensitisers in one- and two-photon photodynamic therapy10.1016/j.ccr.2018.03.020 ↗
18. Photoactivatable organic semiconducting pro-nanoenzymes10.1021/jacs.8b13507 ↗
19. Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application10.1039/D0CS00173B ↗
20. Superoxide radical photogenerator with amplification effect: surmounting the achilles' heels of photodynamic oncotherapy10.1021/jacs.8b13141 ↗
21. Hypoxia-activated NIR photosensitizer anchoring in the mitochondria for photodynamic therapy10.1039/C9SC03355F ↗
22. An emerging molecular design approach to heavy-atom-free photosensitizers for enhanced photodynamic therapy under hypoxia10.1021/jacs.9b09220 ↗
23. Self-assembled nano-photosensitizer for targeted, activatable, and biosafe cancer phototheranostics10.1016/j.biomaterials.2022.121916 ↗
24. A NIR molecular rotor photosensitizer for efficient PDT and synchronous mitochondrial viscosity imaging10.1039/D2CC03592H ↗
25. Glycosylated porphyrins, phthalocyanines, and other porphyrinoids for diagnostics and therapeutics10.1021/acs.chemrev.5b00244 ↗
26. Bright near-infrared aggregation-induced emission luminogens with strong two-photon absorption, excellent organelle specificity, and efficient photodynamic therapy potential10.1021/acsnano.8b03138 ↗
27. Bright aggregation-induced emission nanoparticles for two-photon imaging and localized compound therapy of cancers10.1021/acsnano.0c05610 ↗
28. Engineering lysosome-targeting BODIPY nanoparticles for photoacoustic imaging and photodynamic therapy under near-infrared light10.1021/acsami.6b02721 ↗
29. Recent progress in near infrared light triggered photodynamic therapy10.1002/smll.201702299 ↗
30. Photodynamic-based combinatorial cancer therapy strategies: tuning the properties of nanoplatform according to oncotherapy needs10.1016/j.ccr.2022.214495 ↗
31. Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy10.1021/acs.chemrev.1c00381 ↗
32. The concept and examples of type-III photosensitizers for cancer photodynamic therapy10.1016/j.chempr.2021.10.006 ↗
33. Gold nanoclusters-based nanoprobes for simultaneous fluorescence imaging and targeted photodynamic therapy with superior penetration and retention behavior in tumors10.1002/adfm.201403095 ↗
34. A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging10.1016/j.biomaterials.2010.05.007 ↗
35. Mitochondria-targeted small-molecule fluorophores for dual modal cancer phototherapy10.1002/adfm.201600159 ↗
36. An unexpected strategy to alleviate hypoxia limitation of photodynamic therapy by biotinylation of photosensitizers10.1038/s41467-022-29862-9 ↗
37. D-arginine-loaded metal-organic frameworks nanoparticles sensitize osteosarcoma to radiotherapy10.1016/j.biomaterials.2020.120642 ↗
38. Small-molecule fluorescent probes for plasma membrane staining: design, mechanisms and biological applications10.1016/j.ccr.2022.214862 ↗
39. Water-soluble fluorescent probes for differentiating cancer cells and normal cells by tracking lysosomal viscosity10.1039/D3CC00359K ↗
40. Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities10.1002/med.20092 ↗
41. Nitric oxide signaling in T cell-mediated immunity10.1016/j.molmed.2018.02.002 ↗
42. Nitric oxide induces immunogenic cell death and potentiates cancer immunotherapy10.1021/acsnano.1c09048 ↗
43. Immunomodulatory roles of nitric oxide in cancer: tumor microenvironment says “NO” to antitumor immune response10.1016/j.trsl.2019.03.003 ↗
44. Deep penetration of nanolevel drugs and micrometer-level T cells promoted by nanomotors for cancer immunochemotherapy10.1021/jacs.1c03071 ↗
45. Nitric oxide prodrug delivery and release monitoring based on a galactose-modified multifunctional nanoprobe10.1021/acs.analchem.1c00287 ↗
46. Nitric oxide release: Part II. Therapeutic applications10.1039/c2cs15273h ↗
47. Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies10.1038/s41565-019-0570-3 ↗
48. Recent advances in the development of nitric oxide-releasing biomaterials and their application potentials in chronic wound healing10.1039/D1TB00847A ↗
49. Chemistry of the diazeniumdiolates. 2. Kinetics and mechanism of dissociation to nitric oxide in aqueous solution10.1021/ja002899q ↗
50. Chemistry of the nitric oxide-releasing diazeniumdiolate (“Nitrosohydroxylamine”) functional group and its oxygen-substituted derivatives10.1021/cr000028t ↗
51. Biofouling control in reverse osmosis by nitric oxide treatment and its impact on the bacterial community10.1016/j.memsci.2018.01.012 ↗
52. Diethylenetriamine/NONOate-doped alginate hydrogel with sustained nitric oxide release and minimal toxicity to accelerate healing of MRSA-infected wounds10.1016/j.carbpol.2021.118387 ↗
53. Dual mechanisms of HNO generation by a nitroxyl prodrug of the diazeniumdiolate (NONOate) class10.1021/ja106552p ↗
54. Cardioprotective actions of nitroxyl donor Angeli's salt are preserved in the diabetic heart and vasculature in the face of nitric oxide resistance10.1111/bph.15849 ↗
55. S-nitroso-N-acetylpenicillamine and nitroprusside induce apoptosis in a neuronal cell line by the production of different reactive molecules10.1016/S0014-2999(00)00379-4 ↗
56. Tunable nitric oxide release from S-nitroso-N-acetylpenicillamine via catalytic copper nanoparticles for biomedical applications10.1021/acsami.7b01408 ↗
57. Ceria nanoparticles as an unexpected catalyst to generate nitric oxide from S-nitrosoglutathione10.1002/smll.202105762 ↗
58. Roles and current applications of S-nitrosoglutathione in anti-infective biomaterials
59. Nitric oxide donors: chemical activities and biological applications10.1021/cr000040l ↗
60. Acidity generated by the tumor microenvironment drives local invasion10.1158/0008-5472.CAN-12-2796 ↗
61. Glutathione-depleting nanomedicines for synergistic cancer therapy10.1021/acsnano.1c00498 ↗
62. A core/shell nanogenerator achieving pH-responsive nitric oxide release for treatment of infected diabetic wounds10.1039/D2NR03704A ↗
63. Delivery of nitric oxide with a pH-responsive nanocarrier for the treatment of renal fibrosis10.1016/j.jconrel.2022.12.059 ↗
64. Glutathione responsive β-cyclodextrin conjugated S-nitrothiols as a carrier for intracellular delivery of nitric oxide10.1021/acs.bioconjchem.8b00735 ↗
65. ROS and GSH-responsive S-nitrosoglutathione functionalized polymeric nanoparticles to overcome multidrug resistance in cancer10.1016/j.actbio.2019.12.016 ↗
66. Construction of a multifunctional peptide nanoplatform for nitric oxide release and monitoring and its application in tumor-bearing mice10.1016/j.bios.2023.115313 ↗
67. Photochemical generation of nitric oxide from 6-Nitrobenzo[a]pyrene10.1021/ja0109038 ↗
68. Photoinduced nitric oxide release from nitrobenzene derivatives10.1021/ja0512024 ↗
69. Photoinduced nitric oxide release from a hindered nitrobenzene derivative by two-photon excitation10.1021/ja8093668 ↗
70. Visible light-controlled nitric oxide release from hindered nitrobenzene derivatives for specific modulation of mitochondrial dynamics10.1021/acschembio.5b00962 ↗
71. Photocalibrated NO release from N-nitrosated napthalimides upon one-photon or two-photon irradiation10.1021/acs.analchem.6b01603 ↗
72. A efficient light-controlled nitric oxide releaser in aqueous solution and its red fluorescence imaging in lysosome10.1016/j.dyepig.2020.108247 ↗
73. Light-triggered nitric oxide (NO) release from photoresponsive polymersomes for corneal wound healing10.1039/C9SC04039K ↗
74. Light-triggered nitric oxide release by a photosensitizer to combat bacterial biofilm infections10.1002/chem.202004698 ↗
75. Ring-restricted N-nitrosated rhodamine as a green-light triggered, orange-emission calibrated and fast-releasing nitric oxide donor10.1016/j.cclet.2018.08.019 ↗
76. Influence of nitro ruthenium isomerization on photochemically induced nitric oxide release: vasorelaxant activities10.1016/j.jinorgbio.2023.112166 ↗
77. Vanadyl naphthalocyanine-doped polymer dots for near-infrared light-induced nitric oxide release and bactericidal effects10.1021/acsanm.2c05566 ↗
78. Nitric oxide release activated near-Infrared photothermal agent for synergistic tumor treatment10.1016/j.biomaterials.2021.121017 ↗
79. Nitric-oxide-releasing aza-BODIPY: a new near-infrared J-aggregate with multiple antibacterial modalities10.1002/anie.202207250 ↗
80. A ruthenium-nitrosyl-functionalized nanoplatform for the targeting of liver cancer cells and NIR-light-controlled delivery of nitric oxide combined with photothermal therapy10.1039/C7TB02059G ↗
81. A ruthenium nitrosyl-functionalized magnetic nanoplatform with near-infrared light-controlled nitric oxide delivery and photothermal effect for enhanced antitumor and antibacterial therapy10.1021/acsami.9b18865 ↗
82. Enzyme-triggered size shrink and laser-enhanced NO release nanoparticles for deep tumor penetration and combination therapy10.1016/j.biomaterials.2018.03.046 ↗
83. Killing three birds with one stone: near-infrared light triggered nitric oxide release for enhanced photodynamic and anti-inflammatory therapy in refractory keratitis10.1016/j.biomaterials.2022.121577 ↗
84. Photo-controlled targeted intracellular delivery of both nitric oxide and singlet oxygen using a fluorescence-trackable ruthenium nitrosyl functional nanoplatform10.1039/C4CC09869B ↗
85. Tumor cell specific and lysosome-targeted delivery of nitric oxide for enhanced photodynamic therapy triggered by 808 nm near-infrared light10.1039/C5CC07006F ↗
86. A glutathione-activatable nanoplatform for enhanced photodynamic therapy with simultaneous hypoxia relief and glutathione depletion10.1016/j.cej.2020.126305 ↗
87. Cascade reactions by nitric oxide and hydrogen radical for anti-hypoxia photodynamic therapy using an activatable photosensitizer10.1021/jacs.0c10517 ↗
88. Androgen receptor targeted conjugate for bimodal photodynamic therapy of prostate cancer in vitro10.1021/acs.bioconjchem.5b00261 ↗
89. Sunlight-triggered nanoparticle synergy: teamwork of reactive oxygen species and nitric oxide released from mesoporous organosilica with advanced antibacterial activity10.1021/jacs.5b12073 ↗
90. Dual singlet oxygen and nitric oxide-releasing silicon phthalocyanine for augmented photodynamic therapy
91. Light-triggered nitric oxide nanogenerator with high l-arginine loading for synergistic photodynamic/gas/photothermal therapy
92. Near-infrared light triggered photodynamic and nitric oxide synergistic antibacterial nanocomposite membrane10.1016/j.cej.2020.128049 ↗
93. Surface charge switchable supramolecular nanocarriers for nitric oxide synergistic photodynamic eradication of biofilms10.1021/acsnano.9b05493 ↗
94. In situ generation of peroxynitrite (ONOO−) for enhanced antibacterial photodynamic therapy10.1039/D3TB00058C ↗
95. A unique rectilinearly π-extended rhodamine dye with large Stokes shift and near-infrared fluorescence for bioimaging10.1039/C7CC06220F ↗
96. A general method to increase Stokes shift by introducing alternating vibronic structures10.1021/jacs.8b04404 ↗
97. A review on UV spectrophotometric methods for simultaneous multicomponent analysis
98. The facile synthesis of a single atom-dispersed silver-modified ultrathin g-C3N4 hybrid for the enhanced visible-light photocatalytic degradation of sulfamethazine with peroxymonosulfate10.1039/C8DT00919H ↗
99. Biochemistry of peroxynitrite and protein tyrosine nitration10.1021/acs.chemrev.7b00568 ↗
100. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide10.1073/pnas.87.4.1620 ↗